AIM ImmunoTech Inc.: ceo Thomas K Equels bought 31,675 shares

What happened Thomas K Equels, ceo, president and director, purchased 31,675 shares at $0.16 per share on Oct 23, 2026, for a total reported cash value of $5,068, according to the Form 4 filed with the SEC.

Key details

• Transaction date and price: Oct 23, 2026 — purchase of 31,675 shares at $0.16 per share (transaction code P).
• Shares owned after the transaction: not reported in the Form 4.
• Footnotes: the filing does not list a 10b5-1 plan, tax withholding, or other explanatory footnotes.
• Filing date: Form 4 submitted on Oct 26, 2026; the filing does not indicate it was late.

Why it may matter

• This Form 4 reports a purchase (code P), not an option exercise, award, or gift.
  A filing does not show why the insider traded or why the company acted.